|Min SIP Amount||Not Supported|
|NAV||₹21.96 (24 Jun 2021)|
|Fund Started||25 Mar 2015|
|Fund Size||₹31 Cr|
|Cholamandalam Investment & Finance Co. Ltd.||Financial||Equity||6.3%|
|Gland Pharma Ltd.||Healthcare||Equity||6.3%|
|HDFC Bank Ltd.||Financial||Equity||5.9%|
|Reliance Industries Ltd.||Energy||Equity||5.7%|
|Tube Investments Of India Ltd.||Automobile||Equity||5.6%|
|ICICI Bank Ltd.||Financial||Equity||5.4%|
|MTAR Technologies Ltd.||Services||Equity||5.4%|
|Larsen & Toubro Ltd.||Construction||Equity||5.4%|
|Elgi Equipments Ltd.||Engineering||Equity||5.1%|
|Camlin Fine Sciences Ltd.||Chemicals||Equity||5.0%|
SBI Long Term Advantage Fund Series II Regular Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 25 Mar 2015. Rama Iyer Srinivasan, Nidhi Chawla is the Current Fund Manager of SBI Long Term Advantage Fund Series II Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹31 Cr and the Latest NAV as of 24 Jun 2021 is ₹21.96.
The SBI Long Term Advantage Fund Series II Regular Growth is rated Very High risk.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related instruments of companies along with income tax benefit.